Authorization

Aurora Cannabis Announces Fiscal 2022 First Quarter Earnings Results

Aurora Cannabis Announces Fiscal 2022 First Quarter Earnings Results
Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), announced its financial and operational results late Tuesday for the first quarter of fiscal 2022, ended September 30, 2021.

First Quarter 2022 Highlights

Medical Cannabis:




Net revenue was $41.0 million, a 23% increase from the prior-year period. Adjusted gross margin before fair value adjustments on medical cannabis net revenue was 64% compared to 67% sequentially and 56% in the prior-year period.




"During the quarter, total cannabis net revenue increased by approximately 10% sequentially, driven by our industry-leading and high margin global medical cannabis business. Our premiumization strategy also gained traction, as evidenced by 29% sequential revenue growth in our premium dry flower brands of San Rafael '71 and Whistler, primarily driven by the launch of three new Coast cultivars," stated Miguel Martin, CEO of Aurora Cannabis in a press release.

Consumer Segment:
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Январь 2022    »
ПнВтСрЧтПтСбВс
 12
3456789
10111213141516
17181920212223
24252627282930
31